- Home
- OCGN vs MERC Comparison
OCGN vs MERC Comparison
Compare OCGN & MERC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OCGN
- MERC
- Stock Information
- Founded
- OCGN 2013
- MERC 1968
- Country
- OCGN United States
- MERC Canada
- Employees
- OCGN N/A
- MERC N/A
- Industry
- OCGN Biotechnology: Biological Products (No Diagnostic Substances)
- MERC Paper
- Sector
- OCGN Health Care
- MERC Basic Materials
- Exchange
- OCGN Nasdaq
- MERC Nasdaq
- Market Cap
- OCGN 283.3M
- MERC 271.5M
- IPO Year
- OCGN N/A
- MERC 1987
- Fundamental
- Price
- OCGN $1.03
- MERC $3.23
- Analyst Decision
- OCGN Strong Buy
- MERC Hold
- Analyst Count
- OCGN 3
- MERC 3
- Target Price
- OCGN $6.00
- MERC $4.67
- AVG Volume (30 Days)
- OCGN 1.8M
- MERC 771.0K
- Earning Date
- OCGN 08-01-2025
- MERC 10-30-2025
- Dividend Yield
- OCGN N/A
- MERC 9.29%
- EPS Growth
- OCGN N/A
- MERC N/A
- EPS
- OCGN N/A
- MERC N/A
- Revenue
- OCGN $4,754,000.00
- MERC $1,951,044,000.00
- Revenue This Year
- OCGN N/A
- MERC N/A
- Revenue Next Year
- OCGN N/A
- MERC $13.33
- P/E Ratio
- OCGN N/A
- MERC N/A
- Revenue Growth
- OCGN N/A
- MERC N/A
- 52 Week Low
- OCGN $0.52
- MERC $2.59
- 52 Week High
- OCGN $1.29
- MERC $8.28
- Technical
- Relative Strength Index (RSI)
- OCGN 50.51
- MERC 48.78
- Support Level
- OCGN $1.00
- MERC $3.07
- Resistance Level
- OCGN $1.05
- MERC $3.38
- Average True Range (ATR)
- OCGN 0.04
- MERC 0.15
- MACD
- OCGN 0.00
- MERC 0.02
- Stochastic Oscillator
- OCGN 55.56
- MERC 65.91
About OCGN Ocugen Inc.
Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform, Inhaled Mucosal Vaccine Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").
About MERC Mercer International Inc.
Mercer International Inc is a forest products company with two reportable operating segments in pulp and solid wood. The pulp segment consists of the manufacture, sale, and distribution of pulp, electricity, and chemicals. The company has a geographical presence in the USA, Germany, China, and Other countries, where the majority of revenue is generated from the USA. The majority of the revenue is generated from the Pulp segment.